Spots Global Cancer Trial Database for hyperparathyroidism
Every month we try and update this database with for hyperparathyroidism cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| VATS for Resection of Mediastinal Parathyroids | NCT05696405 | Mediastinal Par... Hyperparathyroi... | VATS resection ... | 18 Years - | Hospital General Ajusco Medio | |
| One Week Comparison Study of PTH and PTHrP Infusions | NCT01333267 | Osteoporosis Hypercalcemia o... Hyperparathyroi... Bone Diseases, ... | Parathyroid Hor... parathyroid hor... PTH (1-34) and ... | 24 Years - 35 Years | University of Pittsburgh | |
| Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention | NCT04040946 | Parathyroid Ade... Hyperparathyroi... F18-choline | MIBI scintigrap... F18-choline PET | 18 Years - | Centre Francois Baclesse | |
| A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) | NCT04064827 | Chronic Kidney ... Secondary Hyper... | Paricalcitol | 0 Years - 9 Years | AbbVie | |
| One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study | NCT00580788 | Osteoporosis Humoral Hyperca... Hyperparathyroi... | PTHrP (1-36) | 24 Years - 35 Years | University of Pittsburgh | |
| Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention | NCT04040946 | Parathyroid Ade... Hyperparathyroi... F18-choline | MIBI scintigrap... F18-choline PET | 18 Years - | Centre Francois Baclesse | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET) | NCT03053999 | Multiple Endocr... Pancreatic Neur... Hyperparathyroi... | Genome Sequenci... Data Review | - | M.D. Anderson Cancer Center | |
| Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention | NCT04040946 | Parathyroid Ade... Hyperparathyroi... F18-choline | MIBI scintigrap... F18-choline PET | 18 Years - | Centre Francois Baclesse | |
| Studies of Elevated Parathyroid Activity | NCT00001277 | Hyperparathyroi... Hypercalcemia Parathyroid Neo... Multiple Endocr... MEN1 | 68Ga-Dotatate 18F-DOPA | 2 Months - | National Institutes of Health Clinical Center (CC) | |
| Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | NCT01219855 | Chronic Kidney ... Secondary Hyper... Vitamin D Insuf... | Cohort 1 CTAP10... Cohort 1 CTAP10... Cohort 1 Matchi... Cohort 2 CTAP10... Cohort 2 Matchi... | 18 Years - 85 Years | OPKO Health, Inc. | |
| Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism | NCT00754442 | Secondary Hyper... | Teriparatide | 40 Years - 59 Years | University of Maryland, Baltimore | |
| Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | NCT01704079 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 30 μg c... Sugar pill to C... | 18 Years - | OPKO Health, Inc. | |
| Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 | NCT02282813 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 Capsule... Calcitriol Doxercalciferol Paricalcitol | 18 Years - | OPKO Health, Inc. | |
| Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy | NCT02205801 | Thyroid Neoplas... Goiter, Nodular Thyroid Nodule Graves' Disease Hyperparathyroi... | Superficial Cer... Local Wound Inf... 0.9% saline Marcaine | 18 Years - | University of Chicago | |
| Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency | NCT01651000 | Chronic Kidney ... Hyperparathyroi... Vitamin D Defic... | CTAP101 30 μg c... Sugar pill to C... | 18 Years - | OPKO Health, Inc. | |
| Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy | NCT05152927 | Parathyroid Dis... Parathyroid Dys... Parathyroid Neo... Parathyroid Ade... Hypercalcemia Neoplasms, Glan... Endocrine Gland... Adenoma Hyperparathyroi... Hyperparathyroi... | Parathyroid Eye... | 18 Years - | University of California, San Francisco | |
| VATS for Resection of Mediastinal Parathyroids | NCT05696405 | Mediastinal Par... Hyperparathyroi... | VATS resection ... | 18 Years - | Hospital General Ajusco Medio | |
| One Week Comparison Study of PTH and PTHrP Infusions | NCT01333267 | Osteoporosis Hypercalcemia o... Hyperparathyroi... Bone Diseases, ... | Parathyroid Hor... parathyroid hor... PTH (1-34) and ... | 24 Years - 35 Years | University of Pittsburgh | |
| Natural History Study of Parathyroid Disorders | NCT04969926 | Parathyroid Can... Primary Hyperpa... Pseudohypoparat... Inheritable Bon... Multiple Endocr... | 6 Months - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy | NCT02205801 | Thyroid Neoplas... Goiter, Nodular Thyroid Nodule Graves' Disease Hyperparathyroi... | Superficial Cer... Local Wound Inf... 0.9% saline Marcaine | 18 Years - | University of Chicago | |
| Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas | NCT02432599 | Hyperparathyroi... | F18-choline PET... | 18 Years - | Centre Francois Baclesse | |
| Bilateral Superficial Cervical Plexus Block in Thyroid/Parathyroid Surgery | NCT04051099 | Benign Tumor of... Hyperparathyroi... | Bilateral super... Dexmedetomidine... Local infiltrai... General anesthe... | 18 Years - | Mahidol University | |
| Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) | NCT01219855 | Chronic Kidney ... Secondary Hyper... Vitamin D Insuf... | Cohort 1 CTAP10... Cohort 1 CTAP10... Cohort 1 Matchi... Cohort 2 CTAP10... Cohort 2 Matchi... | 18 Years - 85 Years | OPKO Health, Inc. | |
| Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) | NCT00792857 | Chronic Kidney ... Secondary Hyper... Chronic Renal I... Chronic Renal F... | CTAP201 Injecti... Doxercalciferol | 18 Years - 80 Years | OPKO Health, Inc. | |
| One Week Comparison Study of PTH and PTHrP Infusions | NCT01333267 | Osteoporosis Hypercalcemia o... Hyperparathyroi... Bone Diseases, ... | Parathyroid Hor... parathyroid hor... PTH (1-34) and ... | 24 Years - 35 Years | University of Pittsburgh | |
| Using X-Ray Dye to Locate Hidden Parathyroid Tumors | NCT00001394 | Parathyroid Neo... | - | National Institutes of Health Clinical Center (CC) | ||
| Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy | NCT02205801 | Thyroid Neoplas... Goiter, Nodular Thyroid Nodule Graves' Disease Hyperparathyroi... | Superficial Cer... Local Wound Inf... 0.9% saline Marcaine | 18 Years - | University of Chicago | |
| Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism | NCT00573573 | Hyperparathyroi... | Far Infrared Ra... | - | GAAD Medical Research Institute Inc. | |
| Bilateral Superficial Cervical Plexus Block in Thyroid/Parathyroid Surgery | NCT04051099 | Benign Tumor of... Hyperparathyroi... | Bilateral super... Dexmedetomidine... Local infiltrai... General anesthe... | 18 Years - | Mahidol University | |
| Studies of Inherited Diseases of Metabolism | NCT00001345 | Multiple Endocr... | 4 Years - | National Institutes of Health Clinical Center (CC) | ||
| Pediatric Chronic Kidney Disease Safety and Efficacy | NCT01277510 | Chronic Kidney ... Hyperparathyroi... Hyperparathyroi... Kidney Disease Secondary Hyper... | cinacalcet caps... placebo Standard of Car... | 6 Years - 17 Years | Amgen | |
| Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis | NCT00537979 | Secondary Hyper... Dialysis | Paricalcitol in... Paricalcitol ca... | 18 Years - | Abbott | |
| Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. | NCT01939977 | Secondary Hyper... | Paricalcitol Calcifediol | 18 Years - | Fundación Senefro | |
| The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry | NCT01409798 | Primary Hyperpa... | 19 Years - | University of Nebraska |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
